FDA warns Westminster International over unapproved COVID-19 fever-screening cameras sold in U.S.
What happened
FDA reviewed the company’s websites on February 25, 2021 and found the WG 520 and WG 620 offered for sale in the U.S. under a “Coronavirus” tab and described as fever, COVID-19, flu, and Ebola screening systems. FDA says the products are intended for COVID-19 use but lack marketing approval, clearance, or authorization. FDA also says multi-person temperature scanning can give incorrect readings and undermine infection control.
What FDA found
The cameras were sold in the U.S. without FDA marketing approval, clearance, or authorization, so FDA calls them adulterated.
section 501(f)(1)(B) of the Act, 21 U.S.C. § 351(f)(1)(B); section 515(a), 21 U.S.C. § 360e(a); section 520(g), 21 U.S.C. § 360j(g)The company did not tell FDA before shipping the products for commercial sale, so FDA calls them misbranded.
section 502(o) of the Act, 21 U.S.C. § 352(o); section 510(k), 21 U.S.C. § 360(k)Website and brochure statements labeled the cameras for COVID-19, flu, Ebola, and other fever screening, making them devices intended for those uses.
section 201(h) of the Act, 21 U.S.C. § 321(h)FDA says multi-person temperature scanning can incorrectly detect fever and may lead people with elevated temperature to skip infection-control steps.
Selling these products in interstate commerce is prohibited.
section 301(a), 21 U.S.C. § 331(a)
What FDA wants
FDA tells the company to immediately stop selling the products for COVID-19 and, within 48 hours, email the COVID-19 Task Force with the specific steps taken, an explanation of steps to prevent recurrence, and related documents.
Who should pay attention
- U.S. buyers of thermal cameras for COVID-19 screening
- distributors and importers of U.K. medical devices
- employers or venues using fever-screening cameras
This is a summary. Read the original letter on fda.gov.